Výnosy Q/Q spoločnosti Novabay Pharmaceuticals Inc
Aká je hodnota metriky Výnosy Q/Q spoločnosti Novabay Pharmaceuticals Inc?
Hodnota metriky Výnosy Q/Q spoločnosti Novabay Pharmaceuticals Inc je -47.94%
Aká je definícia metriky Výnosy Q/Q?
Štvrťročný rast výnosov (Revenue Q/Q) z roku na rok je zvýšenie príjmov firmy v porovnaní s výsledkami v korešpondujúcom štvrťroku minulého roku a vyjadreného v percentách.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Výnosy Q/Q spoločností v sektore Health Care sektor na NYSEMKT v porovnaní so spoločnosťou Novabay Pharmaceuticals Inc
Čomu sa venuje spoločnosť Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Firmy s metrikou výnosy q/q podobnou spoločnosti Novabay Pharmaceuticals Inc
- Hodnota metriky Výnosy Q/Q spoločnosti Future Supply Chain Solutions je -48.03%
- Hodnota metriky Výnosy Q/Q spoločnosti Grand Gulf je -48.03%
- Hodnota metriky Výnosy Q/Q spoločnosti Organovo Inc je -48.00%
- Hodnota metriky Výnosy Q/Q spoločnosti Tata Motors je -47.97%
- Hodnota metriky Výnosy Q/Q spoločnosti Ganfeng Lithium Co je -47.96%
- Hodnota metriky Výnosy Q/Q spoločnosti Kanoria Chemicals & Industries je -47.95%
- Hodnota metriky Výnosy Q/Q spoločnosti Novabay Pharmaceuticals Inc je -47.94%
- Hodnota metriky Výnosy Q/Q spoločnosti Satu je -47.86%
- Hodnota metriky Výnosy Q/Q spoločnosti Eaton Vance Short Duration Diversified Income Fund je -47.85%
- Hodnota metriky Výnosy Q/Q spoločnosti Manfield Chemical je -47.85%
- Hodnota metriky Výnosy Q/Q spoločnosti ShaMaran Petroleum je -47.83%
- Hodnota metriky Výnosy Q/Q spoločnosti Fluence je -47.82%
- Hodnota metriky Výnosy Q/Q spoločnosti Noble je -47.76%